Skip to main content
. 2021 Nov 25;12:764746. doi: 10.3389/fimmu.2021.764746

Table 1.

Association study with newborn IFNAR1 and IFNL SNPs and CZS abnormalities.

No CZS findings CZS Adjusted by trimester of ZIKV exposure and ancestry
N % N % OR lower upper p-value FDR p-value
rs2257167
G/G 56 73.7 38 58.5 1 0.023 0.068
C/G 18 23.7 24 36.9 3.13 1.19 8.21
C/C 2 2.6 3 4.6 5.72 0.77 42.47
G/G 56 73.7 38 58.5 1 0.007 0.032
C/G-C/C 20 26.3 27 41.5 3.41 1.35 8.6
G/G-C/G 74 97.4 62 95.4 1 0.171 0.308
C/C 2 2.6 3 4.6 3.83 0.55 26.97
G/G-C/C 58 76.3 41 63.1 1 0.032 0.072
C/G 18 23.7 24 36.9 2.71 1.07 6.92
Additive 76 53.9 65 46.1 2.76 1.29 5.91 0.006 0.032
 
rs2843710
G/G 30 40 24 36.4 1 0.210 0.629
C/G 36 48 27 40.9 1.15 0.47 2.82
C/C 9 12 15 22.7 2.65 0.85 8.31
C/C 30 40 24 36.4 1 0.340 0.765
C/G-G/G 45 60 42 63.6 1.49 0.65 3.41
C/C-C/G 66 88 51 77.3 1 0.082 0.525
G/G 9 12 15 22.7 2.46 0.87 6.92
C/C-G/G 39 52 39 59.1 1 0.641 1.000
C/G 36 48 27 40.9 0.83 0.37 1.85
Additive 75 53.2 66 46.8 1.55 0.89 2.69 0.117 0.525
rs2834202
A/A 44 58.7 40 62.5 1 0.398 1
A/G 29 38.7 20 31.2 0.87 0.37 2.04
G/G 2 2.7 4 6.2 3.26 0.48 21.89
A/A 44 58.7 40 62.5 1 0.923 1
A/G-G/G 31 41.3 24 37.5 1.04 0.46 2.33
A/A-A/G 73 97.3 60 93.8 1 0.186 1
G/G 2 2.7 4 6.2 3.41 0.52 22.42
A/A-G/G 46 61.3 44 68.8 1 0.605 1
A/G 29 38.7 20 31.2 0.8 0.35 1.85
Additive 75 54 64 46 1.21 0.62 2.36 0.567 1
rs17875834
C/C 72 93.5 56 88.9 1 0.162 0.729
C/T 5 6.5 7 11.1 2.76 0.63 12.06
Additive 77 55 63 45 2.76 0.63 12.06 0.162 0.729
rs12979860
C/C 31 40.3 22 33.3 1 0.608 1
C/T 34 44.2 28 42.4 1.3 0.54 3.15
T/T 12 15.6 16 24.2 1.78 0.56 5.68
C/C 31 40.3 22 33.3 1 0.406 1
C/T-T/T 46 59.7 44 66.7 1.42 0.62 3.25
C/C-C/T 65 84.4 50 75.8 1 0.419 1
T/T 12 15.6 16 24.2 1.54 0.54 4.38
C/C-T/T 43 55.8 38 57.6 1 0.858 1
C/T 34 44.2 28 42.4 1.08 0.48 2.39
Additive 77 53.8 66 46.2 1.33 0.76 2.33 0.319 1
rs8099917
T/T 58 75.3 43 65.2 1 0.309 0.695
G/T 17 22.1 18 27.3 2.09 0.78 5.61
G/G 2 2.6 5 7.6 1.66 0.27 10.11
T/T 58 75.3 43 65.2 1 0.130 0.542
G/T-G/G 19 24.7 23 34.8 2 0.81 4.95
T/T-G/T 75 97.4 61 92.4 1 0.706 1
G/G 2 2.6 5 7.6 1.41 0.23 8.44
T/T-G/G 60 77.9 48 72.7 1 0.154 0.542
G/T 17 22.1 18 27.3 2.02 0.76 5.41
Additive 77 53.8 66 46.2 1.63 0.78 3.37 0.181 0.542
rs8109886
A/A 24 31.2 22 33.3 1 0.795 1
C/A 36 46.8 31 47 0.86 0.34 2.16
C/C 17 22.1 13 19.7 0.68 0.22 2.11
A/A 24 31.2 22 33.3 1 0.622 1
C/A-C/C 53 68.8 44 66.7 0.8 0.34 1.91
A/A-C/A 60 77.9 53 80.3 1 0.548 1
C/C 17 22.1 13 19.7 0.74 0.28 1.98
A/A-C/C 41 53.2 35 53 1 0.971 1
C/A 36 46.8 31 47 1.01 0.46 2.23
Additive 77 53.8 66 46.2 0.83 0.47 1.45 0.505 1
rs4803222
G/G 33 42.9 33 50.8 1 0.909 1
C/G 39 50.6 26 40 0.84 0.36 1.92
C/C 5 6.5 6 9.2 0.84 0.2 3.56
G/G 33 42.9 33 50.8 1 0.662 1
C/G-C/C 44 57.1 32 49.2 0.84 0.38 1.86
G/G-C/G 72 93.5 59 90.8 1 0.904 1
C/C 5 6.5 6 9.2 0.92 0.23 3.67
G/G-C/C 38 49.4 39 60 1 0.713 1
C/G 39 50.6 26 40 0.86 0.39 1.91
Additive 77 54.2 65 45.8 0.88 0.48 1.64 0.694 1
rs368234815
TT/TT 34 44.2 24 37.5 1 0.872 1
TT/ΔG 28 36.4 27 42.2 1.22 0.5 2.95
ΔG/ΔG 15 19.5 13 20.3 1.27 0.43 3.72
TT/TT 34 44.2 24 37.5 1 0.604 1
TT/ΔG-ΔG/ΔG 43 55.8 40 62.5 1.24 0.55 2.76
TT/TT-TT/ΔG 62 80.5 51 79.7 1 0.775 1
ΔG/ΔG 15 19.5 13 20.3 1.16 0.43 3.1
TT/TT-ΔG/ΔG 49 63.6 37 57.8 1 0.771 1
TT/ΔG 28 36.4 27 42.2 1.13 0.5 2.54
Additive 77 54.6 64 45.4 1.14 0.68 1.92 0.624 1

DNA samples from 143 newborns with congenital infection by ZIKV, with or without CZS, were genotyped for IFNAR1 SNPs rs2257167, rs2843710, rs2834202, and rs17875834; and IFNL SNPs rs8109886, rs12979860 rs8099917, rs4803222, and rs368234815. Data were adjusted considering the trimester of the first symptoms or asymptomatic ZIKV infections and the percentage of the African and European ancestry of each individual. The total number of genotyped samples for each SNP may vary due to genotype miscalling. Major allele was used as baseline. Odds ratio (OR) with 95% confidence interval (CI) and p-values. We conducted type I error adjustment of multiple comparisons by the False Discovery Rate (FDR) method.